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Objective: To prospectively study the techniques and outcomes of transcatheter closure of
complex Atrial septal defects (ASD).
Study design and settings: Prospective single center study with experience in catheter closure
of ASD. All patients with complex ASD suitable for device closure.
Objective: Analysis of outcomes of transcatheter closure of complex ASD in JIPMER Hospital
over the past 5-year period.
Methods: Complex ASD was predefined and patients satisfying inclusion and exclusion
criteria are included. All the patients had meticulous Transesophageal echocardiography
(TEE) imaging beforehand. Modifications of the conventional techniques were allowed on a
case per case basis according to operator preference. Successfully intervened patients were
followed up clinically.
Results: Out of the 75 patients enrolled, 69 patients had successful device closure (success
rate 92%) despite challenging anatomy. Fifty-six (74%) patients had ASD 25 mm. Fifteen
patients (20%) had defect size 35 mm and 20 patients (26.6%) had devices implanted with
35 mm waist size. Fifty percent of patients had complete absence of aortic rim and 25%
had deficient posterior rim. Twenty percent of patients had malaligned septum. Mean
follow up period was 3.2 years.
Conclusions: Trans catheter closure is feasible in anatomically complex substrates of
Secundum ASD. Careful case selection, scrupulous imaging protocol, and expertise in
modified techniques are mandatory for successful outcomes.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction
Trans catheter closure for Atrial Septal Defects (ASD) has been
in vogue for more than two decades.1 As the experience and(A.A. Pillai).
2013, Cardiological Societhe techniques evolved, the operators are daring to take up
more challenging defects for the catheter based treatment. No
doubt, surgery remains the gold standard as it carries negli-
gible mortality and 100% operative success rates, not to sayty of India. All rights reserved.
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the technical ease, the comfort of the procedure, lack of a scar
and incredibly less morbidity has taken transcatheter closure
miles ahead in patient and operator preference as the choice
of modality.2. Objective
We analyzed prospectively the pattern, techniques and out-
comes of transcatheter closure of complex atrial septal de-
fects over the past 5 years in our institute.3. Design and settings
Prospective single center registry in a tertiary care hospital
was done. All patients referred for ASD closure were initially
evaluated with transthoracic echocardiography (TTE) and
then with Transesophageal echocardiogram (TEE). In very
small children and infants, transesophageal echowas avoided
if the transthoracic imaging is adequate with details.
3.1. Inclusion criteria
3.1.1. Patients with complex ostium secundum ASD
Definition of complex ASD includes satisfying one of the
following criteria:
1. Large ASD e long axis in any view measuring 25 mm.
2. Malaligned septum.
3. Multiple ASD.
4. ASD with septal aneurysm.
5. ASD with deficiency/floppy posterior or inferior rims with
or without complete absence of aortic rim.
6. ASD with associated lesions like mitral/pulmonic stenosis,
post-tricuspid shunts, coronary anomalies.
3.2. Exclusion criteria
1. Atrial septal defects involving primum and sinus venosus
locations.
2. Pulmonary artery hypertension with hemodynamics sug-
gestive of inoperability.
3. Complete absence of Inferior/Superior vena caval rim.
4. Size more than 44 mm.4. Methods
4.1. Imaging
All patients referred for device closure were scrutinized for
satisfaction of inclusion and exclusion criteria. All adult pa-
tients had a pre procedure TTE as well as TEE. TEE imaging of
all complex defects were done with 120 sweeping in addition
to the standard imaging angles at 0, 45 and 90. The echo was
done in presence of the operators themselves in view of the
complexity of the anatomy. The size of the defect, shape of the
defect, number of defects, and location with regard to mitralvalve, and aortic valve were noted. Each of the important rims
were measured and documented. Malalignment and aneu-
rysm of the septum were also noted.
4.2. Intervention
All procedures in adult patients were done under local anes-
thesia and mild sedation under TEE guidance. Pediatric pa-
tients were subjected to general anesthesia with or without
TEE. All patients had an arterial line with a 5F sheath in view
of predictable long duration of procedure and anticipated
impingement on vital structures as the defects were either
large or with challenging rims. All the procedures were done
under full heparinization with 100 U/kg of unfractionated
heparin and maintenance of ACT between 250 and 300 s. All
patients received a bolus dose of Aspirin 300 mg (4 mg/kg in
pediatric patients) followed by 150 mg daily (2 mg/kg in pe-
diatric patients) for 6 months after successful device closure.
The ASD is crossed with a multipurpose (5F/6F) or Cour-
nard catheter and a 0.03500 Guidewire (Terumo Inc.) and
catheter was parked in the left upper/right upper pulmonary
veins. Exchanged for the 0.03500/0.038 super stiff wire
depending on the support required for large delivery sheaths.
4.3. Modified techniques for complex ASD closures
The ASD closure was attempted in the standardways inmany
patients, and if fails modified techniques was used. In some
patients, where very large devices/floppy rims were present,
we straightway went ahead with modified techniques.
4.4. Balloon sizing of defects
ASD sizing balloon with stop flow technique was used upon
operator’s discretion. In cases where there is a malalignment
defect, defects with septal aneurysm and where there is
suboptimal sizing with TEE, balloon sizing was done with stop
flow echo technique and fluoroscopic measurement.
4.5. Pulmonary vein deployment technique
In this method, the left atrial disc is completely deployed in
the pulmonary vein and keeping the disc in pulmonary vein,
the whole device is stretched out to open the right atrial disc.
Momentary release of the left atrial disc was done when the
right atrial disc fans out to catch out the two sides of the
septum.Wehave used this technique in left upper, right upper
and some times in left lower pulmonary vein.
4.6. Left atrial roof deployment method
The same principle as in pulmonary veins, but the left disc is
opened against the left atrial roof.
4.7. Modified/Cut sheath approach
Here the operator cuts the sheath tip in an oblique fashion to
allow for asymmetric expansion of the left atrial disc to catch
the rims of the defect followed by the asymmetric deployment
Table 1 e Baseline characteristics.
Baseline characteristics n (%) Patientsa
Age (range) 15 monthse64 years
Mean age (years) 21.4
Gender male/female 59/16 (78.6/21.4)
Sinus rhythm 70 (93.3)
Atrial fibrillation 5 (6.6)
Left to right shunt & RV volume overload 75 (100)
RV systolic pressure>40 mmHg 32 (42.6)
Previous stroke 3 (4)
Congestive heart failure 6 (8)
Hypertension 7 (9.3)
Coronary artery disease 3 (4)
RV systolic dysfunction 4 (5.3)
Large ASD (25 mm) 56 (74.6)
Very large ASD (35 mm) 15 (20)
Malaligned septum 17 (22.6)
Multiple/Fenestrated ASD 4 (5.3)
Septal aneurysm 5 (6.6)
Deficient/floppy posterior rim 23 (30.6)
Complete absence of aortic rim 37 (49.3)
ASD with mitral stenosis (Lutembacher’s
syndrome)
1 (1.3)
ASD with valvular PS 2 (2.6)
ASD with PDA 3 (4)
ASD with VSD 1 (1.3)
ASD with partial ALCAPA 1 (1.3)
a n/% ¼ Number/Percentage of patients.
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malaligned septum.
4.8. Dilator/Catheter assisted method
With the help of a contralateral venous access, a long
dilator/Diagnostic catheterewire assembly was kept across
the defect to support the device delivery. This method was
used in some cases of deficient posterior/aortic rims, where
the device tends to slip back in to right atrium in the con-
ventional approach.
4.9. Balloon assisted technique (BAT)
Here again with the help of a contralateral venous sheath, a
highly compliant sizing balloonwas used to occlude the defect
fully or partially for supporting the device delivery. The device
is then delivered from either the left upper / right upper pul-
monary vein and the balloon over the wire placed on the
contra lateral side. With the inflated balloon in situ across the
defect, we deploy the LA disc and then pull back the assembly
to the septum. The balloon supports and prevents prolapse of
the LA disc in to RA and then allows the delivery of the RA disc
outside of the sheath. Then after checking the discs on their
respective sides of the septum by TEE, the operator deflates
the balloon slowly allowing the discs to expand and stent the
septum followed by careful slow and steadywithdrawal of the
balloon. This method was useful in deployment of large de-
vices above 35 mm and with deficient/floppy margins.
We have used the Amplatzer (St. Jude) and Cocoon
(Vascular Innovations) sizing balloons measuring 24 and
34 mm for the balloon assisted technique.Table 2 e Techniques used for device placement.
Technique of intervention n (%)
Balloon assisted technique 21 (29.5)
Left upper/lower pulmonary vein method 16 (22.5)
Right upper pulmonary vein method 11 (15.4)
Modified/cut sheath method 10 (14)
Left atrial roof method 9 (12.6)
Conventional technique 6 (8.4)
Catheter/dilator support 2 (2.8)
Total number of Interventions 715. Results
Of the total number of 169 patients referred for trans catheter
closure of ASD during the period of last 5 years in JIPMER
Hospital from Jan 2008 to Dec 2012, 75 patients had complex
atrial septal defects satisfying the inclusion and exclusion
criteria (44.38%). The baseline characteristics of the patients
are given in Table 1. 17 patients were under the age of 12. The
mean device size was 33.1 mm. The device size chosen was
larger by 2.4e4.9 mm than the measured maximum ASD size
measured.
One patient had Dextrocardia who had a large ASD as part
of Kartagener’s syndrome underwent successful intervention.
5 patients had severe pulmonary artery hypertension (PAH)
with systolic pressures above 70 mmHg. Systolic pulmonary
artery pressures came below 40 mmHg in three patients
immediately post intervention and in one patient during
followup. One patient continues to havemoderate pulmonary
hypertension.
The technique of intervention varied in different patients
(Table 2). Balloon sizing of the ASD was done in 35 patients in
this group according to the operator’s discretion. However it
was done in all cases of septal aneurysm and fenestrated ASD.
In cases where balloon sizing was done, we found a good
correlation between balloon sizing by stop flow echo and
balloon waist measurement by fluoroscopy with a meandifference of 1.6 mm. We did not observe any complications
secondary to balloon sizing.
One patient underwent balloonmitral valvuloplasty before
device closure. Mitral valve area improved to 1.7 cm2 and then
ASD was closed. Two patients had successful balloon opening
pulmonic valve before closing ASD. Patients who had post
tricuspid shunts were closed transcatheter wise before un-
dertaking ASD closure. The patient with ALCAPA had un-
eventful closure of the ASD without any device impingement
on the anomalous artery.5.1. Immediate outcomes
The device closure was successful in 69 patients (success rate
of 92%) The devices used in this study include the double
umbrella type discs {Amplatzer Septal Occluder (St. Jude),
Cocoon Septal Occluder (Vascular Innovations) and Heart R
Septal Occluders (Lifetech)}. In four patients intervention was
unsuccessful. In 3 patients having large defects with deficient
Fig. 1 e Number and sizes of devices used.
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patient developed hemodynamic compromise while device
positioning warranting immediate recapture of the device.
Later it was confirmed that the patient had an anomalous left
circumflex artery from the right sinus coursing transversely
near the septum getting compressed by the device. All these
patients were referred for elective surgical closure. Four pa-
tients had multiple ASD; Use of a larger device resulted inFig. 2 e Serial transesophageal echocardiography images of ball
defect with a 42 mm ASD device (AeF). A) Very large ASD measu
occluding the defect, C) Device in hour glass shape with either
balloon, D) Balloon is deflated and waist expands, E) Device in go
F) Device after deployment.closure of all defects in 2 patients, where as two patients had
small additional defect located far away and could not be
closed with single device. None of the patients in this study
hadmore than one device implanted. There was no procedure
related cardiac tamponade or any vascular complications. All
pediatric patients had an uneventful anesthesia recovery.
There was no sustained arrhythmia or device related throm-
boembolic complications.5.2. Procedure time and fluoroscopy
The complex defects definitely required longer procedure and
fluoroscopic time. The mean fluoroscopic time was 28 min
and procedure time was 52 min.5.3. Follow-up outcomes
The mean follow-up period for the study is 3.2 years (range 6
monthse5 years). All patients who underwent closure had
symptomatic improvement. In large defects with deficient
posterior margin, we observed residual shunting in 5 patients,
but all of them disappeared at follow up TEE done one month
after the procedure. 2 patients had small additional ASD,
which remained patent after intervention. All other patientsoon assisted device closure of a large 38.5 mm atrial septal
ring 38.5 mmwith deficient posterior rim, B) Sizing balloon
discs in respective atria and waist compressed by inflated
od position snugly holding on after removal of the balloon,
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mortality. None of the patients in Atrial fibrillation reverted to
sinus rhythm.
5.4. Closure of very large ASD (35 mm)
Overall 20 patients (26.6%) had devices implanted with more
than 35 mm waist size (Fig. 1). Four patients had 40 mmFig. 3 e Serial fluoroscopic images of balloon assisted device cl
ASD device (AeF). A) Left disc being delivered with balloon inflat
inflated, device assumes a hour glass shape with waist being co
starts deflating, D) The waist expands further as balloon gets s
F) Device deployed after withdrawal of the balloon.implantswhile 2 had 42mmdevices and one patient the largest
in the study i.e. 44 mm. Figs. 2 and 3 show the sequential
echocardiographic and fluoroscopic images of balloon assisted
intervention of an extremely large ASD of 38.5 mm with a
42mmdevice. Video 1 shows balloon assisted device closure in
a patient with large 36 mm defect and posterior malaligned
atrial septum being successfully closed with a 40 mm ASD
occluder.osure of a large 38.5 mm atrial septal defect with a 42 mm
ed across the defect, B) Whole device delivered with balloon
mpressed by the balloon, C) The waist expands as balloon
maller, E) Device in good position after complete deflation,
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http://dx.doi.org/10.1016/j.ihj.2013.12.016.5.5. Complications
Coronary air embolism and transient ST elevation occurred in
5 patients during procedure. But none of them resulted in any
form of hemodynamic compromise. All of them settled
spontaneously with high flow oxygen inhalation.
There were three patients who had device embolization,
two of them on table and the third 5 h after procedure, two to
the pulmonary artery and one device in to the left atrium. All
of them were successfully retrieved percutaneously. Two of
these patients where in the deficient posterior rim and large
size of the defect (38 mm, 35 mm) were the reasons for
instability, were referred for elective surgery. In the third pa-
tient, the complete absence of aortic rim with malaligned
septum made the procedure difficult. Here we downsized the
device size from 24mm to 20mm andwe were successful .We
feel that oversizing the device made high tension on the de-
vice framework which made it prolapse and embolise in to
pulmonary artery.
Two patients developed new onset pericardial effusion
albeit mild, at one month follow up. It was a cause of concern;
both of them were admitted and evaluated for early onset
erosion. No findings of erosion were seen in TEE and
computed tomography and the effusion subsided spontane-
ously. We presume the cause to be metal allergy.
Three patients had mild mitral regurgitation post-proce-
dure and were accepted in view of the large device touching
the anterior mitral valve leaflet. On follow up, none of
the leaks progressed. There was no occurrence of aortic
regurgitation.
Three patients developed aspirin intolerance (gastric side
effects) and needed switching over to clopidogrel.6. Conclusions
Transcatheter closure has become the default treatment
option for ASD closure. Even complex cases can be success-
fully treated with judicious case selection and modified
techniques for device implantation. Our success rate in this
study was 92% with no immediate or late mortality. We had
three cases of device embolization (4%) where the substrate
was large defects with deficient/floppy posterior margin. All
the embolised devices retrieved successfully in the cath lab.
There was no referral for emergency surgery. Balloon sizing
was very useful in predicting device size in cases were TEE
imaging is sub-optimal as in with septal aneurysm. We did
not experience any complications related to balloon sizing.
Our patients did extremely well on clinical follow up. Cath-
eter closure of complex ASD can be done in experienced
centers with very good success rates, however we recom-
mend extreme caution in case selection with TEE playing a
pivotal role in understanding defect characteristics and
planning strategy.7. Discussion
Our study is a single center experience of closing complex
ASD. More than 50% of our study population had defects
more than 30 mm, a subset in which catheter closure is
often challenging. In addition to the size of the defect, un-
derstanding the overall morphology of the septum is
crucial.2 Posterior location, complete absence of aortic rim
and floppy posterior rims are difficult situations for device
positioning.3 Our success rate is 92% with an embolization
rate of 4%, which we think is because of extremely complex
anatomy.
We should understand that the success of complex ASD
closure mainly lies on the proper imaging techniques.4 A
thorough interpretation of the septal anatomy is paramount
to success. Complex anatomical substrates like sinusoidal
septum, aneurysm, and fenestrated defects require careful
delineation before planning intervention.5 We did study all
patients with a detailed transesophageal examination be-
forehand. The pediatric subjects did have good trans thoracic
views and because of logistic reasons, we had to plan in-
terventions without TEE in some of the cases. TEE also is
suboptimal in septal aneurysms and fenestrations/tissue tags
straddling ASD. Balloon sizing was useful in all the cases
where TEE imaging was suboptimal.
Lack of proper aortic rim is often granted for success, but
we found that complete absence of retro aortic tissue is
often challenging because almost always the LA disc flips
tangentially across the defect. Proper alignment almost al-
ways requires one of the modified techniques already
described, especially in large defects with floppy posterior
rims. TEE imaging can add clues in such scenario, if dia-
metrically opposite points in TEE are inadequate, then de-
vice closure is difficult. Short axis (45) TEE would be of great
value for this. We have never attempted a case of absent
inferior vena caval (IVC) rim. Even in cases of deficient
posterior rim, we made sure that a proper IVC rim is there
before deciding for catheter closure. We did not use three
dimensional TEE (3 DTEE), but believe that as we move along
this would be a very useful tool in the future in under-
standing complex septal morphology and thus aid in cath-
eter closures.6 Intracardiac echocardiography (ICE) is
another emerging tool for imaging trans catheter closure of
ASD. But given the learning curve and cost involved in ICE
and the expertise we have over TEE, it surely would take
precedence over ICE for complex defects.7
The crux of the success is the device alignment with
respect to the defect and surrounding structures. In complex
cases, modified techniques would help alignment in more
predictable fashion by allowing the LA disc to remain
expanded over the left side of the septum while the RA disc
fans out over the right side of the septum. Conventional
technique was successful in less than 10% cases in our
study. This essentially helps the device “stent” the defect.
We would like to make a special mention the usefulness of
balloon assisted technique in closing very large defects like
40 mm. The technique proposed by Dalvi et al8 deserves
special mention as we used this technique more often
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 3 8e4 444although we used the sizing balloon supplied along with the
device.
ASD is never a round structure and often it’s oval in shape.
Measurement in long and short axis views is thus helpful in
deciding the device size. In pediatric subsets, we gave
importance to total septal length so as to see whether the left
atrial side which of often smaller would accommodate the
larger (12e14 mm) LA disc. Mitral valve impingement is a
source of another concern, and we did see 2 cases of MR albeit
mild.We did not encounter a case where in two devices would
be required for complete closure of fenestrated defects. We
were able to close the moderately sized adjacent defects with
a single large occluder. But surely large multiple ASD’s situ-
ated farther away in the septum would require multiple de-
vices. Definitely surgery continues to be a gold standard for
complex ASD closure, but we understand that with growing
experience, a significant proportion of the complex defects
could be treated successfully by the percutaneous method
with modified techniques and precise understanding of the
anatomy.Conflicts of interest
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